News
Ahead of ASCO data drop, AZ gets key Imfinzi approval
AstraZeneca has claimed another key FDA approval for Imfinzi in bladder cancer, as an add-on to BCG therapy for early non-muscle invasive disease.
Sunday 14 June 2026
